This story has been updated to include comments from MGI Tech and to correct information about BGI's countersuit against Illumina.
NEW YORK – Illumina has asked a US Court for a preliminary injunction to prevent BGI from distributing sequencers in the US to a handful of labs on a no-cost trial basis.